Causal effects of genetically predicted testosterone on Alzheimer’s disease: a two-sample mendelian randomization study
Authors:
- 25 November 2023
- journal article
- research article
- Published by Springer Nature in Acta Neurologica Belgica
- Vol. 124 (2) , 591-601
Abstract
Objective Although several studies have reported that testosterone may protect against Alzheimer’s disease, no evidence of a causal relationship has been demonstrated. Methods A Mendelian randomization (MR) study was performed to determine the causal role of testosterone in Alzheimer’s disease. The study utilized public databases obtained from separately published genome-wide associationstudies (GWAS). Single-nucleotide polymorphisms (SNPs) for testosterone were extracted from the most recent and largest published GWAS meta-analysis (178,782 participants), and SNPs for Alzheimer’s disease were extracted from UK Biobank (954 AD cases and 487,331 controls). The odds ratio (OR) of the inverse variance weighting (IVW) approach was the primary outcome, and the weighted median and MR Egger regression were used for sensitivity analysis. Results Through IVW, we observed a causal association between genetically predicted testosterone and the risk of Alzheimer’s disease, with an OR of 0.99 (95% confidence interval [CI] = 0.998–0.999, p = 0.047). In the sensitivity analyses, the weighted median regression showed directionally similar estimates (OR = 0.99, 95% CI = 0.998–0.999, p = 0.048). The MR Egger regression showed similar estimates (OR = 0.99, 95% CI = 0.998–1.00, p = 0.35), but with lower precision. Funnel plots, MR Egger intercepts, and Mendelian randomization pleiotropy residual sum and outlier (MR-PRESSO) analysis indicated the absence of directional pleiotropy effects. Conclusion In conclusion, our MR study provides evidence of a causal relationship between testosterone levels and Alzheimer’s disease; however, this relationship must be validated in future studies with larger sample sizes. Early testosterone monitoring may enable the prevention of Alzheimer’s and related diseases.Keywords
This publication has 40 references indexed in Scilit:
- Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized DataGenetic Epidemiology, 2013
- Sex hormones aging and Alzheimer s diseaseFrontiers in Bioscience-Elite, 2012
- Genetic Targeting Aromatase in Male Amyloid Precursor Protein Transgenic Mice Down-Regulates β-Secretase (BACE1) and Prevents Alzheimer-Like Pathology and Cognitive ImpairmentJournal of Neuroscience, 2010
- Effect of Testosterone Supplementation on Functional Mobility, Cognition, and Other Parameters in Older MenJAMA, 2008
- Exogenous Testosterone Alone or With Finasteride Does Not Improve Measurements of Cognition in Healthy Older Men With Low Serum TestosteroneJournal of Andrology, 2007
- Characterization of verbal and spatial memory changes from moderate to supraphysiological increases in serum testosterone in healthy older menPsychoneuroendocrinology, 2007
- Age-Related Testosterone Depletion and the Development of Alzheimer DiseaseJAMA, 2004
- Estrogen and Androgen Protection of Human Neurons against Intracellular Amyloid 1-42 Toxicity through Heat Shock Protein 70Journal of Neuroscience, 2004
- Age Trends in the Level of Serum Testosterone and Other Hormones in Middle-Aged Men: Longitudinal Results from the Massachusetts Male Aging StudyThe Journal of Clinical Endocrinology & Metabolism, 2002
- Testosterone attenuates β-amyloid toxicity in cultured hippocampal neuronsBrain Research, 2001